Venous Thromboembolism Prophylaxis Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Venous Thromboembolism Prophylaxis. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 1: All are predisposing factors of Deep Vein thrombosis, EXCEPT :
- A. Lower limb trauma
- B. Cushing's syndrome
- C. Hip surgery
- D. Subungual melanoma (Correct Answer)
Venous Thromboembolism Prophylaxis Explanation: ***Subungual melanoma***
- This is a rare form of melanoma that develops under the nail, and while serious, it is **not a recognized predisposing factor for deep vein thrombosis (DVT)**. Its primary concerns are local invasion and metastasis.
- Unlike conditions affecting blood clotting or endothelium, **subungual melanoma does not directly promote hypercoagulability, venous stasis, or endothelial damage** that contribute to DVT.
*Lower limb trauma*
- **Trauma to the lower limb** can cause **endothelial damage** to blood vessels and **venous stasis** due to immobility or swelling, both key components of **Virchow's triad** for DVT [1].
- **Fractures or severe soft tissue injuries** often necessitate immobilization and can lead to inflammation, further increasing the risk of clot formation [1].
*Cushing's syndrome*
- **Cushing's syndrome** is associated with **hypercoagulability** due to increased levels of clotting factors, such as **factor VIII** and **fibrinogen**, and decreased fibrinolytic activity.
- The **elevated cortisol levels** seen in Cushing's syndrome [2] can directly contribute to a prothrombotic state, significantly increasing DVT risk.
*Hip surgery*
- **Major orthopedic surgeries**, especially hip surgery [1], are well-known to cause significant **venous stasis** and **endothelial damage**.
- **Post-operative immobility** and a generalized **inflammatory response** following surgery contribute to a high risk of DVT formation [1].
Venous Thromboembolism Prophylaxis Indian Medical PG Question 2: What is the purpose of pneumatic compression stockings?
- A. Prevention of deep vein thrombosis (DVT) (Correct Answer)
- B. Prevention of hypothermia
- C. Management of varicose veins
- D. Treatment of cellulitis
Venous Thromboembolism Prophylaxis Explanation: ***Prevention of deep vein thrombosis (DVT)***
- Pneumatic compression stockings work by **mechanically compressing** the legs, promoting venous return and preventing blood stasis in the deep veins.
- This increased blood flow reduces the risk of **clot formation**, which is crucial in DVT prevention, especially in immobile patients.
*Prevention of hypothermia*
- While stockings might offer a minimal amount of insulation, their primary design and mechanism of action are **not aimed at regulating body temperature**.
- **Other methods** like warming blankets or forced-air warmers are used for the effective prevention of hypothermia.
*Management of varicose veins*
- **Graduated compression stockings** (not pneumatic) are used for the management of varicose veins by providing constant external pressure.
- Pneumatic compression stockings apply **intermittent pressure**, which is not ideal for the continuous support required for varicose vein management.
*Treatment of cellulitis*
- Cellulitis is a **bacterial infection** of the skin and subcutaneous tissue, requiring antibiotic treatment.
- Compression stockings are generally **contraindicated** in acute cellulitis as they can worsen inflammation and impede circulation.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 3: Which of the following drugs is used for treatment of cancer associated thromboembolism?
- A. Direct factor Xa inhibitors
- B. Warfarin
- C. Anti-thrombin III inhibitors
- D. LMW heparin (Correct Answer)
Venous Thromboembolism Prophylaxis Explanation: ***LMW heparin***
- **Low molecular weight heparin (LMWH)** is the **preferred anticoagulant for cancer-associated thrombosis** due to its superior efficacy.
- It has a more predictable pharmacokinetic profile compared to unfractionated heparin and is administered subcutaneously.
*Direct factor Xa inhibitors*
- While effective for general venous thromboembolism (VTE) treatment, some direct oral anticoagulants (DOACs) like factor Xa inhibitors (e.g., rivaroxaban, apixaban) may be considered but have shown mixed results in comparative studies with LMWH for cancer patients, especially those with gastrointestinal cancers, presenting a **higher risk of major bleeding**.
- **LMWH** remains the **first-line choice**, especially in patients with active cancer, given the evidence for its greater efficacy and safety profile in this specific population.
*Warfarin*
- **Warfarin** is generally **not recommended** as a first-line treatment for cancer-associated thromboembolism due to its **drug interactions**, need for frequent monitoring (INR), and slower onset of action.
- Patients with cancer often have fluctuating nutritional status, hepatic dysfunction, and receive other medications that can significantly impact warfarin's effectiveness and safety.
*Anti-thrombin III inhibitors*
- **Antithrombin III inhibitors** (e.g., antithrombin concentrate) are primarily used in specific conditions like **hereditary antithrombin deficiency** or in cases of heparin resistance.
- They are **not a standard treatment** for cancer-associated thromboembolism in the general population of cancer patients.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 4: Surgery in varicose veins is NOT attempted in the presence of which of the following?
- A. Deep vein thrombosis (Correct Answer)
- B. Multiple incompetent perforators
- C. Varicose veins with leg ulcer
- D. None of the above
Venous Thromboembolism Prophylaxis Explanation: ***Deep vein thrombosis***
- **Surgery in varicose veins is absolutely contraindicated in the presence of DVT** (both acute and chronic)
- In **acute DVT**, the deep venous system is already compromised, and removing superficial veins could further impair venous return and worsen the thrombotic state
- In **chronic DVT with post-thrombotic syndrome**, the deep veins may be occluded or heavily damaged, and the superficial varicosities often serve as **crucial collateral vessels** to maintain venous drainage—their removal would be detrimental
- Surgery should only be considered after complete resolution of acute DVT and adequate anticoagulation
*Multiple incompetent perforators*
- **NOT a contraindication**—incompetent perforators are actually a common indication for surgical treatment
- Incompetent perforators contribute to venous insufficiency and recurrent varicose veins
- Can be addressed surgically with **subfascial endoscopic perforator surgery (SEPS)** or endovenous ablation techniques
- Their presence often indicates need for more comprehensive treatment alongside superficial venous surgery
*Varicose veins with leg ulcer*
- **NOT a contraindication**—venous leg ulcers are actually an **indication for varicose vein surgery**
- Leg ulcers result from chronic venous hypertension due to venous insufficiency
- Surgical treatment (saphenous vein ablation, ligation and stripping, or sclerotherapy) reduces venous hypertension and improves venous drainage
- Surgery promotes ulcer healing and prevents recurrence when combined with appropriate wound care
*None of the above*
- Incorrect because **Deep Vein Thrombosis (DVT) is a well-established contraindication** to varicose vein surgery
Venous Thromboembolism Prophylaxis Indian Medical PG Question 5: Arrange the following anticoagulant drugs in ascending order (shortest to longest) based on the pre-operative cessation time before surgery: 1) Clopidogrel 2) Ticlopidine 3) Low molecular weight heparin 4) Warfarin
- A. 2>1>3>4
- B. 4>3>2>1
- C. 3>4>1>2 (Correct Answer)
- D. 3>4>2>1
Venous Thromboembolism Prophylaxis Explanation: ***3>4>1>2***
- The correct order, in ascending time from last dose to surgery, is **low molecular weight heparin (LMWH)** (12-24 hours), **warfarin** (5 days), **clopidogrel** (5-7 days), and **ticlopidine** (10-14 days).
- This order reflects the varying half-lives and durations of action of these anticoagulants and antiplatelet agents.
*2>1>3>4*
- This order is incorrect as it places **ticlopidine** (longest withdrawal) before **clopidogrel** despite ticlopidine having a much longer recommended withdrawal period.
- It also misplaces **LMWH** and **warfarin** in relation to the antiplatelet agents.
*4>3>2>1*
- This order incorrectly positions **warfarin** (5 days) as having the longest pre-surgical hold time, though it is shorter than ticlopidine and clopidogrel.
- It also improperly orders the antiplatelets and **LMWH** with regard to their pre-operative cessation periods.
*3>4>2>1*
- This order incorrectly places **ticlopidine** after **clopidogrel**, when ticlopidine requires a significantly longer cessation period prior to surgery.
- It correctly places **LMWH** and **warfarin** relative to each other, but the antiplatelet order is wrong.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 6: Deep vein thrombosis is MOST common after which of the following procedures?
- A. Neurosurgery
- B. Total hip replacement (Correct Answer)
- C. Gastrectomy
- D. Prostatic operation
Venous Thromboembolism Prophylaxis Explanation: ***Total hip replacement***
- **Total hip replacement surgery** is a significant risk factor for DVT due to extensive tissue trauma, prolonged immobility, and potential damage to venous endothelium during the procedure.
- The incidence of **postoperative DVT** can be as high as 40-60% without prophylaxis, earning it a classification as a **very high-risk procedure** for VTE.
*Neurosurgery*
- While neurosurgery carries a risk of DVT, it is generally **lower compared to major orthopedic surgeries** like total hip replacement.
- The focus in neurosurgery often revolves around avoiding **intracranial bleeding**, which can limit the intensity of anticoagulant prophylaxis.
*Gastrectomy*
- Gastrectomy, a major abdominal surgery, does increase the risk of DVT, but typically **less profoundly than total hip replacement**.
- Risk factors like **anesthesia duration** and degree of inflammation contribute to DVT risk, but not to the same extent as direct trauma to large veins in the lower extremities.
*Prostatic operation*
- **Prostatic operations**, such as prostatectomy, carry a moderate risk of DVT, but this risk is generally **lower than that associated with major orthopedic procedures**.
- The risk is influenced by factors such as **surgical time**, patient age, and the presence of malignancy, but the extent of venous stasis and damage is typically less severe.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 7: In which of the following clinical conditions does the use of anticoagulants provide maximum benefit?
- A. Prevention of recurrences of myocardial infarction
- B. Prevention of venous thrombosis and pulmonary embolism (Correct Answer)
- C. Prevention of cerebrovascular accident (stroke)
- D. Retinal artery thrombosis
Venous Thromboembolism Prophylaxis Explanation: ***Prevention of venous thrombosis and pulmonary embolism***
- Anticoagulants are highly effective in inhibiting the formation and extension of **venous thrombi**, thereby directly preventing **deep vein thrombosis (DVT)** and **pulmonary embolism (PE)**.
- The mechanism of action targets the **coagulation cascade**, directly reducing the risk of these venous thromboembolic events, which are a major indication for anticoagulant therapy.
*Prevention of recurrences of myocardial infarction*
- While anticoagulants may play a secondary role, **antiplatelet agents** (e.g., aspirin, clopidogrel) are the primary therapy for preventing recurrent myocardial infarction, as **arterial thrombi** are predominantly platelet-rich.
- Anticoagulants are used in specific high-risk situations post-MI (e.g., **atrial fibrillation**, left ventricular thrombus) but are not generally considered the primary preventive strategy.
*Cerebrovascular accident*
- The benefit of anticoagulants for stroke prevention is primarily significant in cases of **cardioembolic stroke** (e.g., due to **atrial fibrillation**) where they prevent clot formation in the heart.
- For non-cardioembolic **ischemic strokes** (e.g., thrombotic or lacunar), antiplatelet agents are generally preferred for secondary prevention.
*Retinal artery thrombosis*
- **Retinal artery thrombosis** is often caused by **arterial atherosclerosis** and **embolism** from the carotid arteries or heart, where antiplatelet agents are typically primary.
- The role of anticoagulants here is limited to specific causes like **atrial fibrillation** or in patients already on anticoagulation for other indications.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 8: Which is the most common complication of deep vein thrombosis (DVT)?
- A. Cerebrovascular accident (CVA) - associated with arterial embolism, not DVT
- B. Pulmonary embolism (Correct Answer)
- C. Renal failure - not a common complication of DVT
- D. Myocardial infarction (MI) - a complication of arterial thrombosis, not DVT
Venous Thromboembolism Prophylaxis Explanation: ***Pulmonary embolism***
- A **pulmonary embolism (PE)** occurs when a blood clot, most commonly from a **deep vein thrombosis (DVT)** in the legs, travels to the lungs and blocks an artery [1].
- This is the **most serious and common acute complication** of DVT, potentially leading to respiratory distress, hemodynamic instability, and even death [1].
*Cerebrovascular accident (CVA) - associated with arterial embolism, not DVT*
- A **cerebrovascular accident (CVA)**, or stroke, is most often caused by **arterial embolism** or thrombosis, not typically by venous clots from DVT [1].
- While paradoxical embolism via a patent foramen ovale can occur, it is a **rare mechanism** for CVA from DVT.
*Renal failure - not a common complication of DVT*
- **Renal failure** is not a direct or common complication of DVT; DVT primarily affects the venous system in the limbs and can lead to PE.
- Complications like **post-thrombotic syndrome** are more characteristic of long-term DVT effects on the affected limb.
*Myocardial infarction (MI) - a complication of arterial thrombosis, not DVT*
- A **myocardial infarction (MI)**, or heart attack, is almost exclusively caused by **thrombosis in a coronary artery**, which is part of the arterial system [1].
- DVT involves the venous system, and clots from DVT do not typically travel to the coronary arteries to cause an MI.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 9: Which of the following drugs is used for treatment of cancer associated thromboembolism?
- A. Warfarin
- B. Direct factor Xa inhibitors
- C. LMW heparin (Correct Answer)
- D. Unfractionated heparin
Venous Thromboembolism Prophylaxis Explanation: ***LMW heparin***
- **Low molecular weight heparin (LMWH)** is the preferred treatment for **cancer-associated VTE** due to its superior efficacy and lower risk of recurrent thromboembolism compared to vitamin K antagonists.
- It works by inhibiting activated **factor X (Xa)** and, to a lesser extent, **thrombin (IIa)**, thereby preventing clot formation and propagation.
- **CLOT trial** and international guidelines establish LMWH as the **gold standard** for cancer-associated thromboembolism.
*Warfarin*
- While effective for general VTE, **warfarin** is less effective than LMWH for cancer-associated thrombosis and carries a higher risk of bleeding complications in this patient population due to interactions with cancer treatments and tumor effects.
- It has a **slow onset of action** and requires frequent monitoring of the **International Normalized Ratio (INR)**, making it less practical for initial management in acute settings.
*Direct factor Xa inhibitors*
- **Direct oral anticoagulants (DOACs)** like rivaroxaban and apixaban have shown promise for cancer-associated VTE, but **LMWH** remains the **gold standard**, particularly in the acute phase and in patients with gastrointestinal cancers due to bioavailability concerns with DOACs.
- While they are simpler to administer than warfarin, their efficacy and safety in all cancer subtypes are still under active investigation, and there are concerns about increased **GI bleeding** in some cancer patients.
*Unfractionated heparin*
- **Unfractionated heparin (UFH)** can be used for VTE treatment but requires **continuous IV infusion** and frequent **aPTT monitoring**, making it less practical for outpatient management.
- **LMWH** is preferred over UFH for cancer-associated VTE due to more **predictable pharmacokinetics**, **subcutaneous administration**, and **no need for routine monitoring**, improving patient quality of life and treatment adherence.
Venous Thromboembolism Prophylaxis Indian Medical PG Question 10: What is a potential risk for pregnant women who undertake long journeys with prolonged sitting?
- A. Venous thromboembolism
- B. Deep vein thrombosis (Correct Answer)
- C. Pulmonary embolism
- D. Leg swelling
Venous Thromboembolism Prophylaxis Explanation: ***Deep vein thrombosis***
- **Pregnancy** is a **hypercoagulable state** due to increased levels of clotting factors (fibrinogen, factors VII, VIII, X) and decreased protein S activity.
- **Prolonged sitting** during long journeys causes **venous stasis** in the lower extremities, which is a key component of **Virchow's triad** for thrombosis (stasis, hypercoagulability, endothelial injury).
- **DVT** is the **direct and most specific pathological consequence** of prolonged immobilization during travel in pregnancy.
- The risk of **VTE in pregnancy** is **4-5 times higher** than in non-pregnant women, with travel-related DVT being a recognized complication.
*Venous thromboembolism*
- VTE is an **umbrella term** that encompasses both **DVT and pulmonary embolism**.
- While technically correct as a broader category, DVT is the **more specific and direct answer** to what prolonged sitting causes.
- In medical education and clinical practice, identifying the **specific pathology** (DVT) is more appropriate than using the general category (VTE).
*Pulmonary embolism*
- PE is a **complication** of DVT, occurring when a thrombus dislodges and embolizes to the pulmonary circulation.
- PE is a **secondary consequence**, not the **primary risk** from prolonged sitting itself.
- The direct mechanism of prolonged sitting → venous stasis → **DVT formation** → potential embolization to lungs.
*Leg swelling*
- **Leg swelling** (edema) is a **symptom**, not a pathological diagnosis.
- While leg edema can indicate DVT, it's also common in normal pregnancy due to increased venous pressure and fluid retention.
- The question asks for a **risk** (pathological condition), not a symptom.
More Venous Thromboembolism Prophylaxis Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
